# The Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone Loss

> **NCT03951220** · — · COMPLETED · sponsor: **Oxford University Hospitals NHS Trust** · enrollment: 67 (actual)

## Conditions studied

- Myeloma
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Smouldering Myeloma

## Interventions

- **OTHER:** Diffusion Weighted Magnetic Resonance Imaging (DWMRI)
- **OTHER:** DXA scan
- **OTHER:** Bloods and urine

## Key facts

- **NCT ID:** NCT03951220
- **Lead sponsor:** Oxford University Hospitals NHS Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-29
- **Primary completion:** 2020-12-30
- **Final completion:** 2020-12-30
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2025-08-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03951220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03951220, "The Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone Loss". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03951220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*